Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Luisa Cavalletto"'
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 8, Iss 3, p 30 (2021)
The Fontan operation is the current surgical procedure to treat single-ventricle congenital heart disease, by splitting the systemic and pulmonary circulations and thus permitting lifespan to adulthood for the majority of newborns. However, emerging
Externí odkaz:
https://doaj.org/article/cd6aacb769974d71adac70dd0259dba8
Publikováno v:
Minerva Gastroenterology. 67
Introduction Neurologic and neuropsychiatric manifestations sometimes provide the first evidence of an unknown HCV infection. These conditions develop with a variable ranging of morbidity, including: "brain fog," fatigue, subtle cognitive and attenti
Autor:
Chiara Zanon, Daniela Mancuso, Massimo A. Padalino, Roberta Biffanti, Liliana Chemello, Luisa Cavalletto, Luisa Benvegnù
Publikováno v:
Journal of Cardiovascular Development and Disease
Volume 8
Issue 10
Journal of Cardiovascular Development and Disease, Vol 8, Iss 117, p 117 (2021)
Volume 8
Issue 10
Journal of Cardiovascular Development and Disease, Vol 8, Iss 117, p 117 (2021)
Fontan-associated liver disease (FALD) is an arising clinical entity that can occur long after a successful Fontan operation for correction of single ventricle (SV) congenital heart disease (CHD). Occurrence of FALD is characterized by liver cirrhosi
Autor:
Dante Romagnoli, Elena Turola, Mariagrazia Del Buono, Pamela Sighinolfi, Maria Marsico, Nicola De Maria, Gloria Taliani, Antonino Maiorana, Laura Bristot, Francesca Faillaci, Luca Di Lena, Laura Turco, Liliana Chemello, M.L. Martínez-Chantar, Paolo Magistri, Savino Bruno, Silvia Andreani, Erica Villa, Barbara Lei, Paola Manni, Rosina Maria Critelli, Luisa Cavalletto, L. Marzi, Filippo Schepis, Cristian Caporali, Veronica Bernabucci, Federica D'Ambrosio, Marcello Bianchini, Gianluigi Giannelli, Fabiola Milosa, Paola Todesca, Gabriele Vandelli, Fabrizio Di Benedetto
Publikováno v:
Hepatology (Baltimore, Md.)
Recent reports suggested that direct acting antivirals (DAAs) might favor hepatocellular carcinoma (HCC). In study 1, we studied the proangiogenic liver microenvironment in 242 DAA‐treated chronic hepatitis C patients with advanced fibrosis. Angiop
Autor:
Javier Crespo, Amit G. Singal, Pei-Chien Tsai, Giuseppe Cabibbo, Zoe Mariño, Alberto Zanetto, Elisabetta Degasperi, Xavier Forns, Pierre Nahon, Hiroko Nagata, Calogero Cammà, Francesco Paolo Russo, Mohamed El Kassas, Stefano Brillanti, Mina Nakagawa, Luisa Cavalletto, Tatsuya Minami, Giacomo Emanuele Maria Rizzo, Rob Bielen, Maria Reig, Liliana Chemello, Caitlin C. Murphy, Ming-Lung Yu, Mohamed Kohla, Sarah Shalaby, Gaetano Serviddio, Jose Luis Calleja, Angelo Sangiovanni, Ashraf Omar, Rosanna Villani, Franco Trevisani, Yasuhiro Asahina, Victor Sapena, Jean-François Dufour, Claudio Zavaglia, Fabio Conti, Jordi Bruix, Kévin Jean, Ciro Celsa, José Ríos, Hend Ibrahim Shousha, Nicolás Merchante, Stanislas Pol, C. Masetti, Marco Enea, Ferran Torres, Ryosuke Tateishi, Hidenori Toyoda
Publikováno v:
Gut
Gut, BMJ Publishing Group, 2021, pp.gutjnl-2020-323663. ⟨10.1136/gutjnl-2020-323663⟩
Gut, 2021, pp.gutjnl-2020-323663. ⟨10.1136/gutjnl-2020-323663⟩
Gut, BMJ Publishing Group, 2021, pp.gutjnl-2020-323663. ⟨10.1136/gutjnl-2020-323663⟩
Gut, 2021, pp.gutjnl-2020-323663. ⟨10.1136/gutjnl-2020-323663⟩
ObjectiveThe benefit of direct-acting antivirals (DAAs) against HCV following successful treatment of hepatocellular carcinoma (HCC) remains controversial. This meta-analysis of individual patient data assessed HCC recurrence risk following DAA admin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98dea263eeed558e50d14405e6bd6819
http://hdl.handle.net/11365/1162904
http://hdl.handle.net/11365/1162904
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 8, Iss 30, p 30 (2021)
Journal of Cardiovascular Development and Disease
Journal of Cardiovascular Development and Disease
The Fontan operation is the current surgical procedure to treat single-ventricle congenital heart disease, by splitting the systemic and pulmonary circulations and thus permitting lifespan to adulthood for the majority of newborns. However, emerging
Autor:
Alfredo Alberti, Franco Noventa, Sandro Panese, Sara Piovesan, Diego Tempesta, Francesco Paolo Russo, Maurizio Carrara, Luisa Cavalletto, Giada Carolo, Pier Giorgio Scotton, Liliana Chemello, Georgios Anastassopoulos, T. Bertin, Patrizia Burra, Paolo Angeli, Antonio Carlotto, Antonietta Romano, Franco Capra, Valter Vincenzi, Martina Gambato, Giovanna Scroccaro
Publikováno v:
Journal of hepatology. 69(2)
Direct-acting antiviral agents (DAAs) are safe and effective in patients with hepatitis C. Conflicting data were reported on the risk of hepatocellular carcinoma (HCC) during/after therapy with DAAs. The aim of this study was to evaluate the incidenc
Autor:
Maria Grazia Rumi, Teresa Santantonio, Vincenza Calvaruso, D.C. Amoruso, Giovanni Raimondo, Salvatore Petta, Maria Cristina Pasetto, Romina Corsini, Alfredo Di Leo, Anna Linda Zignego, Barbara Coco, Francesco Paolo Russo, Giovanni Battista Gaeta, Maurizia Rossana Brunetto, Giuseppina Brancaccio, Veronica Bernabucci, Alberto Zanetto, Filomena Morisco, Mario Masarone, Pietro Andreone, Pierluigi Blanc, D. Ieluzzi, Salvatore Madonia, Adele Giammario, Marzia Margotti, Edoardo G. Giannini, M. Cannizzaro, Emanuela Zappulo, Gloria Taliani, Monica Monti, Roberto Filomia, Marco Massari, Guglielmo Borgia, Andrea Iannone, Massimo Siciliano, Erica Villa, Marcello Persico, Stefano Vella, Stefano Rosato, Maria Giovanna Quaranta, L. E. Weimer, Carmine Coppola, Liliana Chemello, Loreta A. Kondili, Barbara Del Pin, Loredana Falzano, Luchino Chessa, L. Donnarumma, Luisa Cavalletto, Elisa Biliotti, Antonio Gasbarrini
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0185728 (2017)
PLoS ONE
PLoS ONE
Background: Few data are available on the virological and clinical outcomes of advanced liver disease patients retreated after first-line DAA failure. Aim: To evaluate DAA failure incidence and the retreatment clinical impact in patients treated in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319d91dddf3ce87a8ea1f347c24a5d39
http://hdl.handle.net/11577/3252831
http://hdl.handle.net/11577/3252831
Autor:
Loreto Boix, Zoe Mariño, Giulio Ceolotto, Antonietta Romano, Valeria Guarneri, Francesco Russo, Maria Reig, Valeria Calvino, Jordi Bruix, Sabela Lens, Alessandra Brocca, Pietro Andreone, Ranka Vukotic, Sofía Pérez-del-Pulgar, Paolo Angeli, Luisa Cavalletto, Saverio Parisi
Publikováno v:
Journal of Hepatology. 70:e354
Autor:
Anna Gottardo, Franca Bilora, Antonio Pagnan, Luisa Cavalletto, Alberto Rossato, Liliana Chemello, Francesco M. Veronese, Valentina Vedovetto
Publikováno v:
Italian Journal of Medicine, Vol 5, Iss 1, Pp 21-27 (2013)
Introduction: Hepatitis C is a major health problem: approximately 170 million people are infected with the hepatitis C virus worldwide. It is unclear whether chronic hepatitis C affects atherosclerosis and whether it can cause endothelial and/or aut